[1]Huang S M, Mishina YM, Liu S, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt sianaling[J]. Nature, 2009, 461(7264):614-620.
[2]Chen B, Dodge ME, Tang W, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer[J]. Nat Chem Biol, 2009,5(2):100-107.[3]Zhi F, Gong G, Xu Y, et al. Activated β-catenin forces N2A cell-derived neurons back to tumor-like neuroblasts and positively correlates with a risk for human neuroblastoma[J]. Int J Biol Sci, 2012, 8(2):289-297.
[4]Jenkins D, Michael O, Mahendroo M, et al. Exon-specific northern analysis and rapid amplification of cdna ends (race) reveal that the proximal promoter ii (pii) is responsible for aromatase cytochrome p450 (cyp19) expression in human ovary[J]. Mol Cell Endocrinol, 1993, 97(1-2):R1-6.
[5]Liang Y, Zhong Z, Huang Y, et al. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells[J]. J Biol Chem, 2010, 285(7):4931-4940.
[6]Maris JM, Matthay KK. Molecular biology of neuroblastoma[J]. J Clin Oncol, 1999, 17(7):2264-2279.
[7]Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma[J]. Lancet, 2007, 369(9579):2106-2120.
[8]Sharp SE, Gelfand MJ, Shulkin B. Pediatrics: diagnosis of neuroblastoma[J]. Semin Nucl Med, 2011, 41(5):345-353.
[9]Bilir A, Erguven M, Yazihan N, et al. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y[J]. J Neurooncol, 2010, 100(3):385-395.
[10]Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group[J]. N Engl J Med, 1999, 341(16):1165-1173.
[11]Pearson AD, Pinkerton CR, Lewis IJ, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial[J]. Lancet Oncol, 2008, 9(3):247-256.
[12]Zage PE, Kletzel M, Murray K, et al. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children’s Oncology Group[J].Pediatr Blood Cancer, 2008, 51(6):747-753.
[13]Lau L, Tai D, Weitzman S, et al. Factors influencing survival in children with recurrent neuroblastoma[J]. J Pediatr Hematol Oncol, 2004, 26(4):227-232.
[14]Laverdière C, Cheung NK, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma[J]. Pediatr Blood Cancer, 2005, 45(3):324-332.
[15]Clevers H. Wnt/beta-catenin signaling in development and disease[J]. Cell, 2005, 127(3):469-480.
[16]Logan CY, Nusse R. The Wnt signaling pathway in development and disease[J]. Annu Rev Cell Dev Biol, 2004, 20(1):781-810.
[17]MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Dev Cell, 2009, 17(1):9-26.
[18]Barker N, Clevers H. Mining the Wnt pathway for cancer therapeutics[J]. Nat Rev Drug Discov, 2006, 5(12):997-1014.
[19]Dregalla RC, Zhou J, Idate RR, et al. Regulatory roles of tankyrase 1 at telomeres and in DNA repair: suppression of T-SCE and stabilization of DNA-PKcs[J]. Aging (Albany NY), 2010, 2(10):691-708.
[20]Damalas A, Ben-Ze’ev A, Simcha I, et al. Excess β-catenin promotes accumulation of transcriptionally active p53[J]. EMBO J, 1999,18(11):3054-3063.
[21]He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway[J]. Science, 1998, 281(5382):1509-1512.
[22]Sun XF, Yin QW, Li XB, et al. The expression of anty-apoptosis protein BAG-1 in non-small cell lung cencerd and its relationship with cell apoptosis and expresson of Bcl-2 [J]. Acta Anatomica Sinica, 2008, 29(4): 557-563. (in Chinese)
孙雪飞,尹秋伟,李希波,等.抗凋亡蛋白BAG.1在非小细胞肺癌组织中的表达及其与细胞凋亡、Bcl.2蛋白表达的关系[J]. 解剖学报,2008,39(4):557-563.
[23]Ma WW, Adjei AA. Novel agents on the horizon for cancer therapy[J]. CA Cancer J Clin. 2010, 60(1):62.
|